title: Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.
abstract: CB1 and CB2 receptors are activated by a plethora of cannabinoid compounds, be they endogenously-produced, plant-derived or synthetic. These receptors are expressed by microglia, astrocytes and astrocytomas, and their activation regulates these cells' differentiation, functions and viability. Recent studies show that glial cells also express cannabinoid-like receptors, and that their activation regulates different cell functions, but also control cell viability. This review summarizes this evidence, and discusses how selective compounds targeting cannabinoid-like receptors constitute promising therapeutics to manage neuroinflammation and eradicate malignant astrocytomas. Importantly, the selective targeting of cannabinoid-like receptors should provide therapeutic relieve without inducing the typical psychotropic effects and possible addictive properties associated with the use of Delta9-tetrahydrocannabinol, the main psychotropic ingredient produced by the plant Cannabis sativa.
authors.affiliation: Department of Pharmacology, Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington 98195-7280, USA. nstella@u.washington.edu
authors.forename: Nephi
authors.initials: N
authors.lastname: Stella
mesh_terms: D000818:Animals; D001253:Astrocytes / Q000378:metabolism*; D001254:Astrocytoma / Q000378:metabolism*; D002186:Cannabinoids / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D017628:Microglia / Q000378:metabolism*; D008959:Models, Neurological; D043884:Receptor, Cannabinoid, CB1 / Q000378:metabolism*; D043885:Receptor, Cannabinoid, CB2 / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000378:metabolism*
chemical_list: D002186:Cannabinoids; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2; D011956:Receptors, Cell Surface
references.citation: FEBS Lett. 1998 Sep 25;436(1):6-10
references.pmid: 9771884
references.citation: Nat Med. 2007 Apr;13(4):492-7
references.pmid: 17401376
references.citation: Glia. 2000 Jan 1;29(1):58-69
references.pmid: 10594923
references.citation: Brain Res Mol Brain Res. 1999 Feb 5;64(2):193-8
references.pmid: 9931487
references.citation: Curr Pharm Des. 2006;12(2):227-39
references.pmid: 16454739
references.citation: Glia. 2009 Feb;57(3):286-94
references.pmid: 18837048
references.citation: Mol Pharmacol. 2006 Jul;70(1):101-11
references.pmid: 16611855
references.citation: Nature. 1999 Jul 29;400(6743):452-7
references.pmid: 10440374
references.citation: AAPS J. 2006 Apr 14;8(2):E272-6
references.pmid: 16796377
references.citation: Eur J Neurosci. 1999 Feb;11(2):691-9
references.pmid: 10051770
references.citation: Stroke. 2002 Aug;33(8):2112-4
references.pmid: 12154273
references.citation: J Biol Chem. 2005 Apr 1;280(13):12212-20
references.pmid: 15657045
references.citation: Biochem Pharmacol. 1999 Apr 1;57(7):727-41
references.pmid: 10075079
references.citation: Peptides. 2000 Nov;21(11):1735-42
references.pmid: 11090929
references.citation: Eur J Pharmacol. 2001 Jul 6;423(2-3):235-41
references.pmid: 11448490
references.citation: Nat Neurosci. 2009 Dec;12(12):1488-90
references.pmid: 19915567
references.citation: J Pharmacol Exp Ther. 2008 Jun;325(3):1007-15
references.pmid: 18354058
references.citation: Blood. 1998 Nov 15;92(10):3605-15
references.pmid: 9808554
references.citation: Neuroscience. 1998 Mar;83(2):393-411
references.pmid: 9460749
references.citation: Neuropharmacology. 2004 Apr;46(5):709-15
references.pmid: 14996548
references.citation: J Biol Chem. 2000 Oct 13;275(41):31938-45
references.pmid: 10913156
references.citation: BMC Neurol. 2006 Mar 02;6:12
references.pmid: 16512913
references.citation: J Cell Sci. 2008 May 15;121(Pt 10):1704-1717
references.pmid: 18445684
references.citation: Trends Pharmacol Sci. 2006 Jan;27(1):1-4
references.pmid: 16318877
references.citation: J Pharmacol Exp Ther. 2007 Jun;321(3):930-7
references.pmid: 17379772
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16511-6
references.pmid: 19805329
references.citation: Br J Pharmacol. 2003 Jun;139(4):775-86
references.pmid: 12813001
references.citation: Neurosci Lett. 2002 Aug 23;329(1):13-6
references.pmid: 12161251
references.citation: J Neurosci. 2007 Sep 5;27(36):9537-44
references.pmid: 17804615
references.citation: Life Sci. 2005 Aug 19;77(14):1685-98
references.pmid: 15963531
references.citation: Neuroscience. 2001;106(1):1-4
references.pmid: 11564411
references.citation: Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):14136-41
references.pmid: 10570211
references.citation: J Neurochem. 1997 Jan;68(1):402-9
references.pmid: 8978752
references.citation: Experientia. 1973 Nov 15;29(11):1368-9
references.pmid: 4761242
references.citation: Mol Pharmacol. 2003 Mar;63(3):699-705
references.pmid: 12606780
references.citation: Br J Pharmacol. 2007 Nov;152(5):699-708
references.pmid: 17704831
references.citation: Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3984-9
references.pmid: 8633002
references.citation: Cell Signal. 2005 Jan;17(1):25-37
references.pmid: 15451022
references.citation: J Neurosci. 2007 Apr 4;27(14):3663-76
references.pmid: 17409230
references.citation: J Neurosci. 2002 Nov 15;22(22):9742-53
references.pmid: 12427829
references.citation: Biochem Biophys Res Commun. 2002 Jan 11;290(1):91-6
references.pmid: 11779138
references.citation: Science. 2005 Oct 14;310(5746):329-32
references.pmid: 16224028
references.citation: Pharmacol Ther. 2005 May;106(2):133-45
references.pmid: 15866316
references.citation: J Neurochem. 1999 Apr;72(4):1759-68
references.pmid: 10098887
references.citation: J Neurochem. 2004 Mar;88(5):1159-67
references.pmid: 15009671
references.citation: Eur J Pharmacol. 1999 Jul 14;377(1):117-25
references.pmid: 10448934
references.citation: Arch Gen Psychiatry. 2001 Apr;58(4):322-8
references.pmid: 11296091
references.citation: J Biol Chem. 2006 Oct 27;281(43):32879-90
references.pmid: 16954222
references.citation: J Neurosci Res. 2002 Mar 15;67(6):829-36
references.pmid: 11891798
references.citation: J Biol Chem. 1995 Jun 9;270(23):13973-80
references.pmid: 7775459
references.citation: Br J Pharmacol. 2003 Apr;138(7):1320-32
references.pmid: 12711633
references.citation: Br J Pharmacol. 2007 Aug;151(8):1343-51
references.pmid: 17592505
references.citation: Eur J Neurosci. 2005 Nov;22(9):2387-91
references.pmid: 16262678
references.citation: Br J Pharmacol. 2007 Dec;152(7):1092-101
references.pmid: 17876302
references.citation: Biochem Biophys Res Commun. 2007 Nov 3;362(4):928-34
references.pmid: 17765871
references.citation: J Pharmacol Exp Ther. 2001 Dec;299(3):951-9
references.pmid: 11714882
references.citation: Cell. 2006 Jan 27;124(2):263-6
references.pmid: 16439202
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4318-23
references.pmid: 9113987
references.citation: J Neurosci. 2001 Feb 1;21(3):823-33
references.pmid: 11157068
references.citation: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7895-900
references.pmid: 16672367
references.citation: Cancer Cell. 2006 Apr;9(4):301-12
references.pmid: 16616335
references.citation: J Neurochem. 2003 Feb;84(3):592-601
references.pmid: 12558979
references.citation: Eur J Neurosci. 2003 Jun;17(12):2750-4
references.pmid: 12823482
references.citation: Eur J Biochem. 1995 Aug 15;232(1):54-61
references.pmid: 7556170
references.citation: Int Immunopharmacol. 2002 Jan;2(1):69-82
references.pmid: 11789671
references.citation: Chem Phys Lipids. 2000 Nov;108(1-2):53-70
references.pmid: 11106782
references.citation: Toxicol Appl Pharmacol. 1997 Feb;142(2):278-87
references.pmid: 9070350
references.citation: Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9561-6
references.pmid: 10920191
references.citation: FEBS Lett. 1994 Aug 22;350(2-3):240-4
references.pmid: 8070571
references.citation: J Neurosci. 2005 Mar 9;25(10):2530-6
references.pmid: 15758162
references.citation: J Neurosci. 1995 Oct;15(10):6552-61
references.pmid: 7472417
references.citation: Nature. 1993 Sep 2;365(6441):61-5
references.pmid: 7689702
references.citation: J Neurochem. 2005 Feb;92(4):895-903
references.pmid: 15686492
references.citation: Exp Neurol. 2007 Jan;203(1):246-57
references.pmid: 17010339
references.citation: J Neurosci. 2003 Dec 3;23(35):11136-41
references.pmid: 14657172
references.citation: J Biol Chem. 2000 May 26;275(21):15621-8
references.pmid: 10821843
references.citation: Br J Pharmacol. 2007 Nov;152(5):734-43
references.pmid: 17906680
references.citation: Mol Pharmacol. 1995 Sep;48(3):443-50
references.pmid: 7565624
references.citation: Science. 2009 Sep 11;325(5946):1349-51
references.pmid: 19745140
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2428-33
references.pmid: 16467152
references.citation: J Pharmacol Exp Ther. 2004 Mar;308(3):838-45
references.pmid: 14617682
references.citation: Mol Pharmacol. 2005 Jan;67(1):15-9
references.pmid: 15465922
references.citation: Mol Pharmacol. 1998 Nov;54(5):834-43
references.pmid: 9804618
references.citation: J Biol Chem. 2000 Jan 7;275(1):605-12
references.pmid: 10617657
references.citation: Mol Pharmacol. 2001 Jul;60(1):155-63
references.pmid: 11408610
references.citation: Nat Med. 2000 Mar;6(3):313-9
references.pmid: 10700234
references.citation: Glia. 2005 Jan 15;49(2):211-9
references.pmid: 15390091
references.citation: J Pharmacol Exp Ther. 1999 Mar;288(3):1357-66
references.pmid: 10027878
references.citation: Experientia. 1973;29(7):825-6
references.pmid: 4724713
references.citation: J Neurochem. 2007 Dec;103(5):1907-16
references.pmid: 17868306
references.citation: J Biol Chem. 2003 Nov 14;278(46):46188-94
references.pmid: 12952947
references.citation: Science. 2003 Oct 3;302(5642):84-8
references.pmid: 14526074
references.citation: Br J Cancer. 2006 Jul 17;95(2):197-203
references.pmid: 16804518
references.citation: Biochem Pharmacol. 2003 Sep 1;66(5):757-67
references.pmid: 12948856
references.citation: J Neurosci. 2005 Feb 23;25(8):1904-13
references.pmid: 15728830
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2699-704
references.pmid: 18263732
references.citation: Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11393-8
references.pmid: 16849427
references.citation: Br J Pharmacol. 2007 Nov;152(5):825-31
references.pmid: 17704827
references.citation: Synapse. 2004 Sep 15;53(4):208-13
references.pmid: 15266552
references.citation: J Pharmacol Exp Ther. 2006 Apr;317(1):428-38
references.pmid: 16352700
references.citation: Nat Rev Cancer. 2004 Jan;4(1):61-70
references.pmid: 14708026
references.citation: J Neurochem. 2005 Oct;95(2):437-45
references.pmid: 16086683
references.citation: Nat Neurosci. 2009 Sep;12(9):1152-8
references.pmid: 19648913
references.citation: Proc Natl Acad Sci U S A. 1992 May 1;89(9):3825-9
references.pmid: 1315042
references.citation: J Clin Invest. 2009 May;119(5):1359-72
references.pmid: 19425170
references.citation: Mol Pharmacol. 1999 Dec;56(6):1362-9
references.pmid: 10570066
references.citation: Eur J Pharmacol. 2000 Apr 21;395(1):1-7
references.pmid: 10781666
references.citation: Mol Pharmacol. 2008 Feb;73(2):441-50
references.pmid: 17965195
references.citation: Arch Toxicol. 2003 Apr;77(4):201-7
references.pmid: 12698235
references.citation: J Nat Prod. 1980 Mar-Apr;43(2):169-234
references.pmid: 6991645
references.citation: Pharmacol Rev. 2002 Jun;54(2):161-202
references.pmid: 12037135
references.citation: PLoS One. 2008 Feb 20;3(2):e1640
references.pmid: 18286196
references.citation: J Immunol. 2006 Oct 1;177(7):4322-9
references.pmid: 16982866
references.citation: J Neurosci. 2003 Aug 27;23(21):7767-75
references.pmid: 12944505
references.citation: Biochem J. 2002 Aug 15;366(Pt 1):137-44
references.pmid: 12010121
references.citation: Neuron. 2008 Mar 27;57(6):883-93
references.pmid: 18367089
references.citation: FEBS Lett. 2009 Jun 18;583(12):2071-6
references.pmid: 19464294
references.citation: J Neurosci. 2002 Jun 1;22(11):4720-7
references.pmid: 12040079
references.citation: Neuropharmacology. 2002 Sep;43(4):503-10
references.pmid: 12367597
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 2004 Mar;369(3):294-9
references.pmid: 14963641
references.citation: FEBS Lett. 1995 Aug 7;369(2-3):177-82
references.pmid: 7544292
references.citation: J Pharmacol Exp Ther. 1999 Jun;289(3):1620-5
references.pmid: 10336560
references.citation: Biochem Biophys Res Commun. 2005 Nov 25;337(3):824-31
references.pmid: 16213464
references.citation: Biochem Biophys Res Commun. 2002 Mar 22;292(1):231-5
references.pmid: 11890697
references.citation: J Neurochem. 2007 Apr;101(2):389-96
references.pmid: 17250681
references.citation: EMBO J. 2001 Jan 15;20(1-2):47-54
references.pmid: 11226154
references.citation: J Neuroimmunol. 1998 Feb;82(1):13-21
references.pmid: 9526841
references.citation: Life Sci. 2005 Aug 19;77(14):1674-84
references.pmid: 16005906
references.citation: J Neurochem. 2006 Aug;98(3):886-93
references.pmid: 16893424
references.citation: J Med Chem. 2004 Jul 15;47(15):3800-6
references.pmid: 15239658
references.citation: Ann N Y Acad Sci. 2006 Aug;1074:514-36
references.pmid: 17105950
references.citation: Neurosci Lett. 1995 Feb 17;186(2-3):91-4
references.pmid: 7777206
references.citation: J Pharmacol Exp Ther. 1999 Dec;291(3):1156-63
references.pmid: 10565837
references.citation: J Neuropathol Exp Neurol. 2004 Sep;63(9):956-63
references.pmid: 15453094
references.citation: Eur J Biochem. 1996 May 1;237(3):704-11
references.pmid: 8647116
references.citation: Mol Pharmacol. 2004 Apr;65(4):999-1007
references.pmid: 15044630
references.citation: Brain Res. 2006 Feb 3;1071(1):10-23
references.pmid: 16472786
references.citation: Br J Pharmacol. 2005 Apr;144(8):1032-6
references.pmid: 15700028
references.citation: Cancer Res. 2001 Aug 1;61(15):5784-9
references.pmid: 11479216
references.citation: Mol Cancer Ther. 2007 Jan;6(1):173-83
references.pmid: 17237277
references.citation: J Neurosci. 2003 Feb 15;23(4):1398-405
references.pmid: 12598628
references.citation: Glia. 2003 Jan 15;41(2):161-8
references.pmid: 12509806
references.citation: PLoS Biol. 2007 Oct;5(10):e269
references.pmid: 17927447
references.citation: Neuron. 2006 Jan 5;49(1):67-79
references.pmid: 16387640
references.citation: Eur J Pharmacol. 2003 Aug 8;474(2-3):195-8
references.pmid: 12921861
references.citation: Pharmacol Ther. 2009 May;122(2):83-96
references.pmid: 19248809
references.citation: Hypertension. 1999 Jan;33(1 Pt 2):429-34
references.pmid: 9931142
references.citation: Glia. 1996 Sep;18(1):1-10
references.pmid: 8891687
references.citation: FASEB J. 2009 Jan;23(1):183-93
references.pmid: 18757503
references.citation: J Pharmacol Exp Ther. 1996 Sep;278(3):989-99
references.pmid: 8819477
references.citation: J Biol Chem. 1996 Aug 9;271(32):19238-42
references.pmid: 8702604
references.citation: Nature. 1990 Aug 9;346(6284):561-4
references.pmid: 2165569
references.citation: Nature. 1995 Aug 17;376(6541):590-4
references.pmid: 7637807
references.citation: Cell Mol Life Sci. 2006 Sep;63(17):2057-66
references.pmid: 16909207
references.citation: Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4668-73
references.pmid: 10200320